Kelly Rogers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Tennessee Health Science CenterPharmD, 1994
Publications & Presentations
PubMed
- 12 citationsUse of Cilostazol in Percutaneous Coronary InterventionsKelly C. Rogers, Jenna M Faircloth, Shannon W. Finks
The Annals of Pharmacotherapy. 2012-06-01 - 3 citationsThe Fall Risk with Alpha blockers Given InitiaL dose or Elderly status (FRAGILE) StudyChelsea C McDonnell, Kelly C. Rogers, Sloan M Regen, Shannon W. Finks
The Annals of Pharmacotherapy. 2020-03-01 - 42 citationsClinical efficacy and safety of cilostazol: a critical review of the literature.Kelly C. Rogers, Carrie S. Oliphant, Shannon W. Finks
Drugs. 2015-03-11
Journal Articles
- Clinical Communications Nitrate Allergy and Desensitization in a Patient with Refractory AnginaKelly C Rogers, Amanda R Gillion, Debendra Pattanaik, ScienceDirect
Office
881 Madison Ave
Memphis, TN 38163
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
